Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | -$0 | $5 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 32.9% | -14.6% | -2.6% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 53.8% | 52.4% | 62.5% | 63.7% |
| EBITDA | $0 | $0 | $0 | $2 |
| % Margin | 18.5% | 18.2% | 18.6% | 167.9% |
| Net Income | $0 | $0 | $0 | $2 |
| % Margin | 6.7% | 1.6% | 4.2% | 156.9% |
| EPS Diluted | 0.16 | 0.028 | 0.087 | 3.37 |
| % Growth | 463.4% | -67.4% | -97.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |